PIVEKIMAB
UNII B7BU7JJ4PP

Substance Identification & Data

This profile provides standardized clinical and technical data for Pivekimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B7BU7JJ4PP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2234335-84-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B7BU7JJ4PP

CAS Registry Number

2234335-84-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PIVEKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C184869

National Cancer Institute reference terminology for clinical and research data.

INN ID

11693

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-168

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pivekimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PIVEKIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (446-CYSTEINE), ANTI-(HUMAN INTERLEUKIN 3 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL G4723A .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL G4723A .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL3RA (INTERLEUKIN 3 RECEPTOR SUBUNIT ALPHA, INTERLEUKIN 3 RECEPTOR, ALPHA (LOW AFFINITY), CD123)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV1-46*01 (80.6%)-(IGHD)-IGHJ4*01 (100%), CDR-IMGT (8.8.14) (26-33.51-58.97-110)) (1-121)-HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 D12 (360), L14 (362), S122>C (446) (345-449), CHS K2>DEL (450)) (122-450)), (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV14-111*01 (83.2%)-IGKJ2*03 (83.3%) S120>Q (100), L124>V (104)/HOMO SAPIENS IGKV1-16*01 (82.1%)-IGKJ2*01 (91.7%) L124>V (104), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (230-230'':233-233'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA

PIVEKIMAB [INN]

PIVEKIMAB [USAN]